TY - JOUR
T1 - Diabetes : intravitreous ranibizumab for proliferative diabetic retinopathy
AU - Gibson, Jonathan M.
AU - McGinnigle, Samantha
N1 - -
PY - 2016/1/22
Y1 - 2016/1/22
N2 - The Diabetic Retinopathy Clinical Research Network has published the 2-year results of a 5-year study comparing intravitreous ranibizumab with panretinal laser photocoagulation in patients with proliferative diabetic retinopathy. The results suggest that intravitreous ranibizumab will become a valuable treatment option, although its exact role remains to be defined.
AB - The Diabetic Retinopathy Clinical Research Network has published the 2-year results of a 5-year study comparing intravitreous ranibizumab with panretinal laser photocoagulation in patients with proliferative diabetic retinopathy. The results suggest that intravitreous ranibizumab will become a valuable treatment option, although its exact role remains to be defined.
KW - diabetes complications
KW - drug therapy
KW - eye diseases
UR - http://www.scopus.com/inward/record.url?scp=84958109950&partnerID=8YFLogxK
UR - https://www.nature.com/articles/nrendo.2016.1
U2 - 10.1038/nrendo.2016.1
DO - 10.1038/nrendo.2016.1
M3 - Letter, comment/opinion or interview
C2 - 26794438
AN - SCOPUS:84958109950
SN - 1759-5029
VL - 12
SP - 130
EP - 131
JO - Nature Reviews Endocrinology
JF - Nature Reviews Endocrinology
IS - 3
ER -